FDA Approvals in Oncology: July-September 2024
This quarter’s 16 approvals include a first-in-class cell therapeutic, a flurry of new options for EGFR-mutated lung cancer, and...
Tag: Sarcoma
This quarter’s 16 approvals include a first-in-class cell therapeutic, a flurry of new options for EGFR-mutated lung cancer, and...
The AACR journal editors' picks for July 2024 include a review of the risks from CAR T-cell therapy, advances...
Researchers are making progress on genetic classification of sarcoma tumors, the use of T-cell therapy, and nanomedicine delivery.
Most scientists, regardless of field or career stage, have faced difficulties networking and disseminating their research in the past year, with many conferences and symposia canceled. The...
The first new anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) in 2020 are for the...
Late last week, the U.S. Food and Drug Administration (FDA) approved a new treatment for one of the most...
The flurry of anticancer therapeutics approved by the U.S. Food and Drug Administration (FDA) late last month included the...